The Delhi High Court allowed

to supply remaining Olymviq stock to government hospitals after a 30-day stock clearance window. The company agreed to discontinue Olymviq, transition to Olymra, and withdraw trademark applications. Justice Jyoti Singh formalized the settlement, ensuring unsold inventory can be supplied to government hospitals with Novo Nordisk's presence.